One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study.
Aliment Pharmacol Ther. 2021 Jun;53(12):1300-1308. doi: 10.1111/apt.16388. Epub 2021 Apr 28.
Aliment Pharmacol Ther. 2021.
PMID: 33909911
Clinical Trial.